Skip To Main Content
Caelan Barranta on Muck Rack

Caelan Barranta

As seen in: The Journal of Clinical Investigation, Texas Medical Center
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Caelan

Contact Caelan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Outpatient COVID-19 Convalescent Plasma Recipient Antibody Thresholds Correlated to Reduced Hospitalizations Within a Randomized Trial

|
By Han-Sol Park, Anna Yin, Caelan Barranta, John Lee
| Texas Medical Center
COVID-19 convalescent plasma (CCP) virus-specific antibody levels that translate into recipient posttransfusion antibody levels sufficient to prevent disease progression are not defined. This secondary analysis correlated donor and recipient antibody levels to hospitalization risk among unvaccinated, seronegative CCP recipients within the outpatient, double-blind, randomized clinical trial that compared CCP to control plasma.
Open in Who Shared Issue with article?

Outpatient COVID-19 convalescent plasma recipient antibody thresholds correlated to reduced hospitalizations within a randomized trial

|
By JCI Insight, Han-Sol Park, Anna Yin, Caelan Barranta
| The Journal of Clinical Investigation
Clinical MedicineCOVID-19 Open Access | 10.1172/jci.insight.178460 JCI Insight. https://doi.org/10.1172/jci.insight.178460. Copyright © 2024, Park et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. View PDF Abstract Supplemental material Version history Version 1 (March 14, 2024): In-Press Preview
Open in Who Shared View Duplicates (2) Issue with article?
See all 2 articles